Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vax-DC/MM in Relapsed or Refractory Multiple Myeloma
NCT02248402Phase 2Unknown
- Sponsor
- Chonnam National University Hospital
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Vax-DC/MM in multiple myeloma (MM), sponsored by Chonnam National University Hospital. Status: unknown.
02
Drugs
Vax-DC/MM
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02248402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02248402.